Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Additional conditions recognized in this trial
			Astrocytoma
			Brain Neoplasms
			Central Nervous System Neoplasms
			Nervous System Neoplasms
			Oligodendroglioma
2		More general conditions related to this trial
			Brain Diseases
			Central Nervous System Diseases
			Glioma
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Germ Cell and Embryonal
			Neoplasms, Glandular and Epithelial
			Neoplasms, Nerve Tissue
			Neoplasms, Neuroepithelial
			Nervous System Diseases
			Neuroectodermal Tumors
3		Interventions listed in this trial
			imatinib mesylate
4		Additional drug interventions recognized in this trial
			Imatinib
5		More general drug interventions related to this trial
			Antineoplastic Agents
			Enzyme Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Protein Kinase Inhibitors
			Therapeutic Uses
6		Sponsors listed in this trial
			North Central Cancer Treatment Group
			National Cancer Institute (NCI)